However, luminal tumors expressing ERα and identified as invasive ductal carcinoma (IDC) represent the majority of BC at the time of diagnosis and tend to have a more favorable prognosis compared to breast tumors that do not express ERα (5–8). This evidence concerns the gene ESR1 and breast neoplasm.